Novavax and Sorrento Therapeutics: Are These Beaten-Down Coronavirus Stocks a Bargain?The Motley Fool • 11/16/20
Novavax to Host Conference Call for Questions Related to Third Quarter Financial and Operating Results on November 10, 2020GlobeNewsWire • 11/10/20
Novavax Didn't Come Close to Analysts' Q3 Estimates -- and It's No Big DealThe Motley Fool • 11/10/20
Novavax, Inc. (NVAX) CEO Stan Erck on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha • 11/10/20
Coronavirus vaccine frontrunner Pfizer delivers key trial data – here's where the other vaccines standCNBC • 11/09/20
Novavax leaps 7% after its COVID-19 vaccine won US FDA fast-track authorizationBusiness Insider • 11/09/20
Novavax Rallies After FDA Accords Fast Track Designation For Investigational Coronavirus VaccineBenzinga • 11/09/20